ReviewPharmaceuticals (Basel, Switzerland)2026

Next-Generation Biomarkers in Multiple Myeloma: Advancing Diagnosis, Risk Stratification, and Precision Therapy Beyond Current Guidelines.

Marta Marques de Carvalho Lopes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.